Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Marie Mi Bonde"'
Autor:
Belinda von Niederhäusern, Stefan Schandelmaier, Marie Mi Bonde, Nicole Brunner, Lars G Hemkens, Marielle Rutquist, Neera Bhatnagar, Gordon H Guyatt, Christiane Pauli-Magnus, Matthias Briel
Publikováno v:
PLoS ONE, Vol 12, Iss 7, p e0180635 (2017)
OBJECTIVE:To systematically survey existing definitions, concepts, and criteria of clinical research quality, both developed by stakeholder groups as well as in the medical literature. This study serves as a first step in the development of a compreh
Externí odkaz:
https://doaj.org/article/c896cbee6f884b2b9cfe0d31471191ea
Autor:
Marie Mi Bonde, Jonas Tind Hansen, Samra Joke Sanni, Stig Haunsø, Steen Gammeltoft, Christina Lyngsø, Jakob Lerche Hansen
Publikováno v:
PLoS ONE, Vol 5, Iss 11, p e14135 (2010)
Seven transmembrane receptors (7TMRs) can adopt different active conformations facilitating a selective activation of either G protein or β-arrestin-dependent signaling pathways. This represents an opportunity for development of novel therapeutics t
Externí odkaz:
https://doaj.org/article/86819fd62a8e44de89068ff9032481c4
Publikováno v:
Regulatory Affairs Watch. 3:4-7
Patient and public involvement (PPI) describes the active engagement of patients and the public in different aspects of clinical research. This Deep Dive article covers the current situation of PPI in academic clinical research in Switzerland, giving
Autor:
Marie Mi Bonde Hansen
Publikováno v:
Regulatory Affairs Watch. 3:33-35
Because of their lived experience, patients provide unique insights and perspectives on clinical research studies. This article presents two case studies from the University Hospital Basel that illustrate how researchers and patients can collaborate
Autor:
Sharon B. Love, Christiane Pauli-Magnus, Patricia Arnaiz Jimenez, Marie Mi Bonde, Nicole Bruni, Matthias Briel, Pascal Benkert, Matthew R. Sydes, Hannah Ewald, Katharina Klatte
Publikováno v:
Cochrane Database Syst Rev
BACKGROUND: Trial monitoring is an important component of good clinical practice to ensure the safety and rights of study participants, confidentiality of personal information, and quality of data. However, the effectiveness of various existing monit
Autor:
Gordon H. Guyatt, Belinda von Niederhäusern, Matthias Briel, Marie Mi Bonde, Stefan Schandelmaier, Lars G. Hemkens, Nicole Brunner, Marielle Rutquist, Christiane Pauli-Magnus, Neera Bhatnagar
Publikováno v:
PLoS ONE, Vol 12, Iss 7, p e0180635 (2017)
PLoS ONE
PLoS ONE
Objective To systematically survey existing definitions, concepts, and criteria of clinical research quality, both developed by stakeholder groups as well as in the medical literature. This study serves as a first step in the development of a compreh
Autor:
Samra Joke Sanni, T Speerschneider, Gitte Lund Christensen, Marie Mi Bonde, Steen Gammeltoft, Jakob Lerche Hansen, JT Hansen, S Munk
Publikováno v:
British Journal of Pharmacology. 161:150-161
BACKGROUND AND PURPOSE The angiotensin II type 1 (AT1) receptor belongs to family A of 7 transmembrane (7TM) receptors. The receptor has important roles in the cardiovascular system and is commonly used as a drug target in cardiovascular diseases. In
Autor:
Jennifer L. Whistler, Srinivasan Madabushi, Marie Mi Bonde, Jakob Lerche Hansen, Jian-Nong Ma, Rong Yao, Søren P. Sheikh, Ethan S. Burstein, Stig Haunsø, Olivier Lichtarge
Publikováno v:
Bonde, M M, Yao, R, Ma, J-N, Madabushi, S, Haunsø, S, Burstein, E S, Whistler, J L, Sheikh, S P, Lichtarge, O & Hansen, J L 2010, ' An Angiotensin II type 1 receptor activation switch patch revealed through Evolutionary Trace analysis ', Biochemical Pharmacology, vol. 80, no. 1, pp. 86-94 . https://doi.org/10.1016/j.bcp.2010.03.006
Udgivelsesdato: 2010-Mar-21 Seven transmembrane (7TM) or G protein-coupled receptors constitute a large superfamily of cell surface receptors sharing a structural motif of seven transmembrane spanning alpha helices. Their activation mechanism most li
Publikováno v:
Journal of Molecular and Cellular Cardiology. 46:15-24
The angiotensin AT 1 receptor is an important pharmacological target in the treatment of cardiovascular disorders, such as hypertension, diabetic nephropathy, cardiac hypertrophy, arrhythmia and failure. Simultaneously, the AT 1 receptor has emerged
Publikováno v:
Nucleic Acids Research
Nucleic Acids Research, Oxford University Press, 2014, 42 (20), pp.12847-12860. ⟨10.1093/nar/gku1014⟩
Nucleic Acids Research, Oxford University Press, 2014, 42 (20), pp.12847-12860. ⟨10.1093/nar/gku1014⟩
Splicing reactions generally combine high speed with accuracy. However, some of the pre-mRNAs escape the nucleus with a retained intron. Intron retention can control gene expression and increase proteome diversity. We calculated the escape rate for t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41c523772f62eb0272f4070a0f10cad8
https://hal.archives-ouvertes.fr/hal-02179569/file/islandora_55186.pdf
https://hal.archives-ouvertes.fr/hal-02179569/file/islandora_55186.pdf